Navigation Links
Reportlinker Adds Injectable Drug Delivery: Market Impact and Industry Trends
Date:11/10/2009

NEW YORK, Nov. 10 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue.

Injectable Drug Delivery: Market Impact and Industry Trends

http://www.reportlinker.com/p0158352/Injectable-Drug-Delivery-Market-Impact-and-Industry-Trends.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire

As competition in the pharmaceutical marketplace grows, companies are increasingly looking towards the drug delivery industry to maximize revenues and combat generic competitors. The search for more efficient drug delivery systems is also being driven by the rise in patient demand, healthcare and pharma cost containment, as much as by medical and technological advances.

The global market for drug delivery technology is worth in excess of US$25 billion in sales. Given its predicted annual growth of 15 percent, the market represents a considerable business opportunity, which has been reflected in the increasing number of drug delivery specialists. According to The author; new report entitled Injectable Drug Delivery: Market Impact and Industry Trends, injectables currently account for an estimated 15 percent of the global drug delivery market, with the US being the leading individual market.

Key features of this report:

  • Overview of the drug delivery environment
  • In-depth analysis of the injectable drug delivery industry, including main types and main marketed systems, and their advantages and disadvantages
  • Comprehensive facts and figures for the injectable drug delivery market, including main players and key therapeutic areas
  • Future trends in the injectables marketplace, shaped by medical and technological advances as much as demographic and epidemiological changes and industry needs
  • Outlook for the injectable drug delivery technology

Who should buy this report?

  • Stakeholders in the injectable drug delivery market
  • Companies interested in understanding the impact and implications of securing the correct injectable drug delivery technology in terms of product placement, lifecycle management and competition in the marketplace
  • Companies interested in understanding future opportunities in the injectable drug delivery sector provided by a combination of factors, including changing public health needs
  • Pharma/biotech companies wishing to identify potential injectable drug delivery areas for partnerships and collaboration in order to examine a variety of profit maximization strategies

1. Executive Summary

2. Introduction to Drug Delivery

2.1. Drug Delivery Technologies and Pharmaceutical Revenues

2.2. Drug Delivery Technologies and Wider Healthcare Market

3. Overview of Injectable Drug Delivery

3.1. Advantages and Disadvantages of Injectable Delivery

3.2. Types of Injectable Drug Delivery

4. Main Categories of Marketed Injectable Drug Delivery Systems

4.1. Sustained Release Injectable Systems

4.2. Advantages of Injectable Sustained-Release Formulations

4.3. Liposomal Systems

4.4. Advantages of Injectable Liposomal Formulations

4.5. Needleless Systems

4.6. Advantages of Injectable Needleless Formulations

5. Injectable Drug Delivery Market - Facts and Figures

5.1. Injectable Drug Delivery Market Overview

5.2. Key Therapeutic Areas for Injectable Drug Delivery

5.3. Acromegaly

5.4. Age-Related Macular Degeneration

5.5. Crohn's Disease

5.6. Diabetes

5.7. Hepatitis C

5.8. Multiple Sclerosis

5.9. Neutropenia

5.10. Oncology

5.11. Pain

5.12. Psoriasis

5.13. Rheumatoid Arthritis

6. Drug Classes Appropriate for Injectable Drug Delivery

7. Main Players and Partnerships in the Injectable Drug Delivery Market

8. Key Company Involvement in the Field of Injectable Drug Delivery

8.1. Alkermes

8.2. ALZA

8.3. Aradigm

8.4. Bioject

8.5. Enzon

8.6. Ethypharm

8.7. MacroMed

8.8. Nektar Therapeutics

8.9. QLT

8.10. SkyePharma

9. Sales of Products Utilizing Injectable Drug Delivery Technology

10. Profiles of Key Products Using Injectable Drug Delivery Technology

10.1. Neulasta (Nektar/Amgen)

10.2. PEGASYS (Roche/Nektar)

10.3. PEG-Intron (Schering-Plough)

10.4. Risperdal Consta

10.5. Sandostatin (Novartis)

10.6. Vivitrol (Alkermes)

11. Recent Launches and Approvals in the Field of Injectable Drug Delivery

11.1. August 2006

11.2. July 2006

11.3. May 2006

11.4. April 2006

11.5. February 2006

11.6. January 2006

12. Current Research and Profiles of Key Pipeline Products in the Field of Injectable Drug Delivery

12.1. Cimzia (Nektar)

12.2. Mircera/CERA (Nektar)

12.3. Paliperidone Palmitate (Johnson & Johnson)

12.4. Intraject Sumatriptan (Zogenix)

13. Future of Injectable Drug Delivery Technology

13.1. Emerging Injectable Drug Delivery Technologies

13.2. Emerging Therapeutic Targets for Injectable Drug Delivery

13.3. Future Therapeutic Targets for Injectable Drug Delivery

13.4. New Technology and the Injectable Drug Delivery Market

13.5. New Threats to the Injectable Drug Delivery Market

13.6. New Healthcare Needs and the Injectable Drug Delivery

14. Outlook for Injectable Drug Delivery Technology

List of Tables

Table 2.1 Drivers of New Drug Delivery Technologies

Table 2.2 Advantages of New Drug Delivery Technology

Table 3.1 Types of Injectable Delivery

Table 4.1 Key Companies in the Needleless Drug Technology Market

Table 5.1 Leading MS Therapy Delivery Routes and Dosage

Table 5.2 Key Biologics for the Treatment of Psoriasis

Table 5.3 Administration Methods of Main RA Therapies

Table 7.1 Leading Injectable Drug Delivery Companies 2005, Key Products and Sales 2005 ($ mn)

Table 7.2 Novartis' Pipeline Major Drug Delivery Partners

Table 8.1 Key Details of Main Companies in the Field of Injectable Drug Delivery

Table 8.2 Alkermes' Injectable Drug Delivery Portfolio, 2006

Table 8.3 Bioject's Injectable Drug Delivery Portfolio, 2006

Table 8.4 Enzon's Injectable Drug Delivery Portfolio, 2006

Table 8.5 Ethypharm's Injectable Drug Delivery Portfolio, 2006

Table 8.6 MacroMed's Injectable Drug Delivery Portfolio, 2006

Table 8.7 Nektar's Injectable Drug Delivery Portfolio, 2006

Table 8.8 SkyePharma's Injectable Drug Delivery Portfolio, 2006

Table 9.1 Key Injectable Drug Delivery Products, 2004-2005 ($ mn)

Table 10.1 GH Suppression During Long-Term Treatment with Immediate Release Sandostatin Injection and Sandostatin LAR Depot

Table 10.2 Comparison of Acromegaly Symptoms with Immediate Release Sandostatin Injection and Sandostatin LAR Depot as Reported by Patients

Table 13.1 Key Injectable Drug Delivery R&D Pipeline Drugs, 2006

Table 13.2 Other Viral and Bacterial Infections to Which Injectable Technology is Applicable

Table 13.3 Emerging Therapeutic Areas for Injectable Drug Delivery

Table 13.4 DOR BioPharma Drug Delivery Portfolio, 2006

Table 14.1 Drivers and Restraints of Injectable Drug Delivery

List of Graphs

Graph 5.1 2005 Sales of Leading MS Therapies

Graph 5.2 2005 Sales of Leading Psoriasis Biologics

Graph 5.3 2005 Sales of Leading RA Therapies

Graph 7.1 Leading Injectable Drug Delivery Companies, Combined Key Product Values 2005 ($ mn)

Graph 7.2 Leading Companies Active in Injectable Drug Delivery Development, Number of Products

Graph 9.1 Top Ten Products Utilizing Injectable Delivery, Global Sales 2005 ($ mn)

List of Figures

Figure 4.1 Patient Perception of Iject and Associated Pain

Figure 8.1 Illustration of ALZAMER's PLGA Solvent Control over Protein Release

Figure 8.2 Advanced PEGylated Drug Molecules

Figure 8.3 Four Stages of Photodynamic Therapy

Figure 12.1 Illustration of NanoCrystal Dispersion's Advantages

Figure 13.1 Comparison of Morphine Delivery Technologies: Oral, Injectable and Transmucosal

Diagrams

Diagram 4.1 Rheumatoid Arthritis Treatment Guidelines

Diagram 4.2 The American College of Rheumatology Criteria (ACR) Criteria

To order this report: Injectable Drug Delivery: Market Impact and Industry Trends

http://www.reportlinker.com/p0158352/Injectable-Drug-Delivery-Market-Impact-and-Industry-Trends.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire

More market research reports here!

    Nicolas Bombourg
    Reportlinker
    Email: nbo@reportlinker.com
    US: (805)-652-2626
    Intl: +1 805-652-2626

SOURCE Reportlinker


'/>"/>
SOURCE Reportlinker
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Reportlinker Adds The Future of the Wound Care Management Market to 2015
2. Reportlinker Adds The Prescribing Data Restriction Program: Critical Assessment and Best Practices
3. Reportlinker Adds The Global Drug Delivery Market: Research Trends and Market Outlook
4. Reportlinker Adds Pharmaceutical Pricing, Reimbursement and Parallel Trade 2006
5. Reportlinker Adds Pain Therapeutics 2005: Market Dynamics and Outlook
6. Reportlinker Adds Blood and Lymphatic System Hyperlipemia
7. Reportlinker Adds Infections Ear Infections
8. Reportlinker Adds Wheelchair Market Shares, Strategies, and Forecasts, Worldwide, 2009 to 2015
9. Reportlinker Adds Impact of Counterfeits on Parallel Trade & Pharmaceutical Distribution: Issues, initiatives and insights for supply chain integrity
10. Reportlinker Adds Contract Pharmaceutical Manufacturing, Research and Packaging
11. Reportlinker Adds Gastrointestinal Pharmaceuticals: Technologies and Markets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... Research and Markets has announced ... Market Prospects: Addressing Production Complexities Through Risk Management and ... ... Pipeline and Market Prospects: Overcoming Production Complexities Through Risk ... of the current trends in the global biosimilars market, ...
(Date:4/20/2017)... , April 20, 2017 Research and ... Technologies - Innovation Driven by Rapidly Expanding Injectables Market and Increasing ... their offering. ... for drug delivery technologies will rise from USD 20 Billion in ... Global Drug Delivery Technologies - Innovation Driven by Rapidly Expanding ...
(Date:4/20/2017)... --  ZappRx, Inc ., a digital health company focused on ... it closed $25 million in Series B funding led by ... Seattle that is part of a ... B round included participation from SR One , who ... (formerly Google Ventures). As part of the financing, ...
Breaking Medicine Technology:
(Date:4/25/2017)... ... 25, 2017 , ... A recent report from the Wisconsin ... the 2015-16 school year across Wisconsin’s public schools, charter schools, and private schools ... in student test score performance, the report’s limited analyses fail to provide answers ...
(Date:4/25/2017)... ... April 25, 2017 , ... As pharmaceutical companies are held ... with process innovation in drug formulation and manufacturing. CoreRx offers its clients ... equipment in support of their development and manufacturing goals. , The company ...
(Date:4/25/2017)... ... ... Chaudhary, MD is committed to providing the highest quality of spine care to all his ... with all my patients to alleviate possible future issues. I am pleased to have you ... and my trained staff will assist you in any way possible.” , Dr. Saad Chaudhary ...
(Date:4/25/2017)... ... 25, 2017 , ... Vetoquinol USA® , a world-class ... part of the EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event in ... immunologic level. , The scientifically-developed Flexadin UCII supports the body’s normal repair of ...
(Date:4/24/2017)... Nashville, TN (PRWEB) , ... April 24, 2017 , ... ... electrifying fans and transforming the quarterback position. The former overall number one pick in ... his professional football career. He holds the record for the most career rushing yards ...
Breaking Medicine News(10 mins):